About Biobeat
Biobeat is revolutionizing hypertension care through its groundbreaking cuffless ambulatory blood pressure monitoring (ABPM) system. The company's FDA-cleared, medical-grade chest patch enables continuous 24-hour blood pressure monitoring without the discomfort and sleep disruption of traditional cuff-based systems. Using proprietary patented PPG (photoplethysmography) sensor technology, Biobeat's wireless monitoring solution addresses critical gaps in hypertension diagnosis and management, including white coat syndrome and masked hypertension. The system automatically generates comprehensive reports that provide clinicians with crucial insights into patients' blood pressure patterns throughout day and night, enabling more effective treatment planning and better patient outcomes. Biobeat's approach eliminates patient anxiety associated with traditional monitoring methods while improving compliance through enhanced comfort. The company serves cardiologists, nephrologists, and hypertension centers across major health systems in the United States and is expanding internationally. Validated against gold standard cuff-based monitoring and published in the American Journal of Hypertension, Biobeat's solution supports ACC/AHA guideline recommendations for 24-hour monitoring to confirm hypertension diagnosis. The company is driven by a mission to ensure all hypertension patients are monitored and managed effectively, leveraging the latest advancements in wearable technology and data analytics to transform healthcare delivery.
Mission & Story
Mission
To ensure all hypertension patients are monitored and managed effectively
Founding Story
Founded by Arik Ben Ishay (CEO), Johanan May (SVP & CTO), and Israel Sarussi (SVP R&D) to address challenges in accurately diagnosing and treating hypertension patients by providing complete and accurate information to allow physicians to make informed decisions
Clinical Focus
Medical conditions and clinical areas addressed by Biobeat.
Who It Serves
Milestones & Awards
Recent Milestones
Secured $50 million Series B financing (December 2025), launched integrated patient diary (November 2025), named Rising Star winner at HLTH Digital Health Awards (October 2025), won 2026 HMH Emerge Program (March 2026), expanded to Argentina, Chile, and Dominican Republic (August 2025)
Awards & Recognition
HLTH Digital Health Awards Rising Star winner (October 2025), HMH Emerge Program winner (2026)
Key Partnerships
Social & Media
Latest Updates
Continuous Blood Pressure Monitor
Understanding and Operationalizing Continuous ABPM Monitoring in Hospital-at-Home Programs
How Biobeat is Transforming the 24 hour ambulatory blood pressure monitoring (ABPM) experience for both hypertension patients & doctors
Unlocking The Potential Of Artificial Intelligence & Machine Learning in Healthcare
Addressing Racial Disparities in Hypertension: Evaluating the Effectiveness of Biobeat Across All Skin Tones
Company Details
- Headquarters
- Boca Raton, FL, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 63 →
Acurable
Acurable creates accurate and user-friendly wearable medical devices for at-home monitoring of sleep apnea, epilepsy, COPD, and asthma.
Aktiia
Aktiia develops optical blood pressure monitoring technology integrated into wearable devices for continuous, cuffless blood pressure tracking. The company focuses on enabling remote patient monitoring and hypertension management through clinically validated wearable solutions.
August Health
August Health provides an AI-enabled EHR platform designed specifically for senior living communities. The platform includes integrated modules for electronic health records, medication management (eMAR), move-ins, billing, care tracking, and predictive analytics to help operators shift from reactive to proactive care strategies.
Babyscripts
Babyscripts is a market-leading digital maternity care platform that combines remote patient monitoring, care management, and patient engagement tools to improve maternal health outcomes across prenatal and postpartum care for health systems, payers, and private practices.
Belun Technology Company
11-50 employees
Belun Technology develops FDA-cleared AI-powered wearable ring technology for sleep apnea diagnosis and continuous health monitoring. The company provides medical-grade sleep diagnostics that bridge the gap between home and hospital care.
Binah.ai
Binah.ai provides an AI-powered, video-based, 100% software solution that enables measurement of vital signs and health indicators using smartphone or tablet cameras. In 35 seconds, users can measure vital signs, chronic disease risks, stress levels, and bloodless blood tests without wearables or equipment.
Biofourmis
growth · 350 employees
Biofourmis provides a connected technology platform that partners with health systems, hospitals, and payers to revolutionize care delivery across the continuum.
BioIntelliSense
BioIntelliSense provides continuous patient monitoring solutions through its BioButton wearable device, enabling proactive detection of patient deterioration in both hospital and home settings. The system delivers real-time vital sign data to clinicians through cloud-based analytics.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.